Quarterly report [Sections 13 or 15(d)]

Nature of Business and Significant Accounting Policies (Details)

v3.25.1
Nature of Business and Significant Accounting Policies (Details) - USD ($)
 3 Months Ended 9 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Feb. 28, 2025
Feb. 29, 2024
May 31, 2024
May 31, 2023
Nature of Business and Significant Accounting Policies (Details) [Line Items]            
Cash and Cash Equivalents, at Carrying Value $ 220,683   $ 220,683   $ 600,007 $ 998,421
Accounts Receivable, Credit Loss Expense (Reversal) 3 $ 93 0 $ 393    
Inventory Write-down     205,180 0    
Goodwill 557,896   557,896   $ 557,896  
Other Nonoperating Income 0 0 50,103 924,862    
Net Income (Loss) Attributable to Noncontrolling Interest 0 168 0 2,368    
Advertising Expense 75,527 125,251 250,237 352,310    
Research and Development Expense $ 180 $ 1,286 $ 601 $ 3,173    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)     21,915,669 20,726,901    
Kealii Okamalu, LLC [Member]            
Nature of Business and Significant Accounting Policies (Details) [Line Items]            
Subsidiary, Ownership Percentage, Noncontrolling Owner 50.00%   50.00%      
CLS CBD [Member]            
Nature of Business and Significant Accounting Policies (Details) [Line Items]            
Equity Method Investment, Ownership Percentage 95.00%   95.00%      
Kealii Okamalu, LLC [Member]            
Nature of Business and Significant Accounting Policies (Details) [Line Items]            
Equity Method Investment, Ownership Percentage 50.00%   50.00%      
Warrant [Member]            
Nature of Business and Significant Accounting Policies (Details) [Line Items]            
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)     14,398,169 8,250,000    
Convertible Debt Securities [Member]            
Nature of Business and Significant Accounting Policies (Details) [Line Items]            
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)     7,500,000 57,715,202    
Stock Payable [Member]            
Nature of Business and Significant Accounting Policies (Details) [Line Items]            
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)     17,500 17,500    
Equity Option [Member]            
Nature of Business and Significant Accounting Policies (Details) [Line Items]            
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)       83,709,603